Somatoform and panic disorders are associated with atypical chest pain. Pain expression is mild, accompained with panic. Predictive factors for atypical chest pain are: age under 40, anxiety level >20, somatization > or =63, presence of panic and somatoform disorders, H-R score >102, and a lack of positive diagnostic test of coronary disease. Defining of these parameters could be useful for early psychiatric evaluation of persons with atypical chest pain.
After acute cardiac event, hospitalized coronary patients had a mild anxiety, depression and aggression level as well as after six months. The infarct patients had experienced more stress life events in the previous year than the angina patients. Risk health behaviour did not change in the following six months, with the increased smokers' rate in the angina group. Alcohol consumption, smoking and heredity were predictive for rehospitalization.
Because of their biological, and, especially, psychological and social characteristics, psychiatric patients can often become victims of very different modalities of activities which cause harm to them. These factors exist and have origin in social context where mentally ill live, but they can be factors that belong to whole social community as well. The aim of this paper is to review factors which contribute to victimisation of psychiatric patients, to point out a risk of their victimisation and their specific predispositions, as well as negative social circumstances which make psychiatric patients vulnerable to become victims in broader sense. In addition, the proposal of possible typology of psychiatric patients as victims is included as well
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.